B-Type Natriuretic Peptide Levels and Cardiac Dysfunction in Children on Peritoneal Dialysis

Young Seo Park1, Jae Suk Baek1, Jeong Jin Yu1

  • 1Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, South Korea.

Insights

Serum B-type natriuretic peptide (BNP) levels correlate with cardiac abnormalities in children undergoing peritoneal dialysis (PD). Routine BNP measurement can help assess cardiovascular risk in these patients.

Area of Science:

  • Pediatric Nephrology
  • Cardiology
  • Biomarkers

Background:

  • Patients on peritoneal dialysis (PD) exhibit high rates of left ventricular (LV) abnormalities.
  • Cardiovascular mortality risk is significantly elevated in PD patients compared to healthy individuals.

Purpose of the Study:

  • To investigate the association between serum B-type natriuretic peptide (BNP) levels and echocardiographic cardiac parameters in children on PD.
  • To determine the utility of serum BNP as a risk assessment tool for cardiac issues in pediatric PD patients.

Main Methods:

  • Retrospective chart review of echocardiographic findings in 52 children on PD.
  • Linear regression analysis of log(BNP) against various cardiac parameters, including LV structure, function, and dimensions.
  • Annual or semi-annual echocardiography, with increased frequency for patients with hypertension or cardiac conditions.

Main Results:

  • Serum BNP levels positively correlated with increased blood pressure, LV posterior wall thickness, LV internal diameter, LV mass index, interventricular septum thickness, and left atrial dimensions.
  • BNP levels also showed positive correlations with parameters like lateral E/E' and lateral A'/E', indicating diastolic dysfunction.
  • Conversely, BNP levels negatively correlated with LV fractional shortening, LV ejection fraction, and right ventricular function parameters.

Conclusions:

  • Serum BNP is a valuable biomarker for detecting cardiac morphological and functional changes in children on PD.
  • Routine measurement of serum BNP is recommended to proactively evaluate and manage cardiovascular risk in pediatric PD patients.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
744
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
587
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
794
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
506
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.4K